- Home
- FGEN vs VRAR Comparison
FGEN vs VRAR Comparison
Compare FGEN & VRAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FGEN
- VRAR
- Stock Information
- Founded
- FGEN 1993
- VRAR 2016
- Country
- FGEN United States
- VRAR United States
- Employees
- FGEN N/A
- VRAR N/A
- Industry
- FGEN Biotechnology: Pharmaceutical Preparations
- VRAR Retail: Computer Software & Peripheral Equipment
- Sector
- FGEN Health Care
- VRAR Technology
- Exchange
- FGEN Nasdaq
- VRAR Nasdaq
- Market Cap
- FGEN 33.5M
- VRAR 33.3M
- IPO Year
- FGEN 2014
- VRAR 2021
- Fundamental
- Price
- FGEN $7.26
- VRAR $1.49
- Analyst Decision
- FGEN Strong Buy
- VRAR Strong Buy
- Analyst Count
- FGEN 1
- VRAR 1
- Target Price
- FGEN $250.00
- VRAR $2.62
- AVG Volume (30 Days)
- FGEN 74.7K
- VRAR 135.2K
- Earning Date
- FGEN 08-05-2025
- VRAR 05-15-2025
- Dividend Yield
- FGEN N/A
- VRAR N/A
- EPS Growth
- FGEN N/A
- VRAR N/A
- EPS
- FGEN N/A
- VRAR N/A
- Revenue
- FGEN $6,996,000.00
- VRAR $8,756,789.00
- Revenue This Year
- FGEN N/A
- VRAR $23.96
- Revenue Next Year
- FGEN N/A
- VRAR $12.15
- P/E Ratio
- FGEN N/A
- VRAR N/A
- Revenue Growth
- FGEN N/A
- VRAR N/A
- 52 Week Low
- FGEN $4.50
- VRAR $0.50
- 52 Week High
- FGEN $38.25
- VRAR $7.00
- Technical
- Relative Strength Index (RSI)
- FGEN 60.54
- VRAR 52.95
- Support Level
- FGEN $5.37
- VRAR $1.31
- Resistance Level
- FGEN $5.73
- VRAR $1.38
- Average True Range (ATR)
- FGEN 0.49
- VRAR 0.11
- MACD
- FGEN 0.27
- VRAR 0.01
- Stochastic Oscillator
- FGEN 83.80
- VRAR 66.67
About FGEN FibroGen Inc
FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Geographically, it operates in United States, Japan, Europe and Others.
About VRAR The Glimpse Group Inc.
The Glimpse Group Inc is a diversified Virtual and Augmented Reality platform company, comprised of multiple VR and AR software and services companies, and designed with the specific purpose of cultivating companies in the emerging VR/AR industry.